Company Profile

Aspen Pharmacare (OTC: APNHY)
2:15 PM UTC, 07/03/24
Last: $12.55 Change: +0.09 %Change: +0.72% Volume: 105
Detailed Quote
Open: $ 12.55   Volume: 105
High: $ 12.55   Yield(%) 1.02
Low: $ 12.55   P/E Ratio (ttm): 20.81
Dividend ($): 0.13   Market Cap ($): 5.49B
EPS ($) n/a   Shares Out: 444.24M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -1.62
% Price Change (last 13 weeks): 5.76
% Price Change (last 26 weeks): 14.09
% Price Change (last 52 weeks): 26.19
% Price Change (year to date): 11.07
Management Effectiveness
Return on Equity (%): 6.61
Return on Assets (%): 4.23
Return on Invested Capital (%): 6.22
Profitability
Gross Profit Margin (%): 44.59
Net Profit Margin (%): 12.84
Operating Profit Margin (%): 22.03
Price & Volume
50-day Moving Average: $6.11
200-day Moving Average: $3.71
Avg. Daily Vol. (last 50 days): 382
Avg. Daily Vol. (last 200 days): 268
52-wk high: $13.44
52-wk low: $8.35
Bid: $n/a
Ask: $n/a
Company Information
Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. It operates through the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals segment consists of the following business sub segments: Sterile Focused Brands, which includes the Anaesthetics and Thrombosis portfolios; and Regional Brands, which are products that are managed on a regional basis. The Manufacturing segment focuses on the following business sub segments: Active Pharmaceutical Ingredients, which involved in API Chemicals business and non-heparin biochemical API business; Heparin, which refers to the full value chain contribution from all heparin containing products; FDF Steriles, which includes all FDF sterile sales; and FDF Other, which consists of all non-sterile FDF products. The company was founded by Michael Guy Attridge and Stephen Bradley Saad in 1850 and is headquartered in Durban, South Africa.
Aspen Pharmacare
Aspen Place, 9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge
Durban NL 4019

Phone: 27.31.580.8600
Fax: n/a
http://www.aspenpharma.com
Per Share Data
Earnings (1year) ($): 0.59
Annual Dividend ($): 0.13
Current P/E Ratio (ttm): 20.81
Book Value ($): 10.28
Cash Flow ($): 0.89
Valuation Ratios
Price/Earnings (x): 20.81
Price/Sales (x): 1.88
Price/Book (x): 0.95
Price/Cash Flow (x): 13.90
Financial Strength
Quick Ratio (x): 1.08
Current Ratio (x): 1.92
LT Debt/Equity (x): 24.79
Total Debt/Equity (x): 33.96



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.